Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Colorectal Disease
Published in: International Journal of Colorectal Disease 12/2022

Open Access 28-11-2022 | Crohn's Disease | Study Protocol

Effect of immunosuppressive medication on postoperative complications following abdominal surgery in Crohn’s disease patients

Authors: Saleh Lahes, Celine Fischer, Antonios E. Spiliotis, Antje Schulz, Gereon Gäbelein, Dorian Igna, Matthias Glanemann

Published in: International Journal of Colorectal Disease | Issue 12/2022

Login to get access

Abstract

Background

Immunosuppressants represent an effective pharmacological treatment for the remission and management of Crohn’s disease (CD); however, it has not been well-defined if these medications are associated with an increased incidence of postoperative complications after intestinal surgery. This retrospective study evaluated the association between immunosuppressive treatment and complications following bowel resection in patients with CD.

Methods

A total of 426 patients with CD who underwent abdominal surgery between 2001 and 2018 were included in the study. The participants were divided into two groups. In the first group, patients were under immunosuppressive treatment at the time of surgical resection, while in the second group, patients had never received pharmacological therapy for CD before surgery.

Results

No statistically significant difference was found in the incidence of postoperative complications between the two groups. Double or triple immunosuppressive therapy was not associated with increased complications compared to monotherapy or no pharmacological treatment. Preoperative risk factors such as hypoalbuminemia, abscess, fistula, intestinal perforation, long duration of symptoms, and the intraoperative performance of more than one anastomosis were related to increased rates of postoperative complications. Factors affecting the occurrence of postoperative complications in the univariate analysis were included in the multivariate analysis using a stepwise logistic regression model, and these factors were also related to increased rates of postoperative surgical complications.

Conclusion

Immunosuppressive therapy was not associated with increased rates of postoperative complications following bowel resection in patients with CD.
Literature
1.
Moller FT, Andersen V, Wohlfahrt J, Jess T (2015) Familial risk of inflammatory bowel disease: a population-based color study 1977–2011. Am J Gastroenterol 110:205–271CrossRef
2.
Molodocky NA, Soon IS, Rabi DM et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time. Based on systematic review Gastroenterol 142:46–54
3.
Adamina M, Bonovas S, Raine T, Spinelli A, Warusavitarne J, Armuzzi A, Bachmann O, Bager P, Biancone L, Bokemeyer B, Bossuyt P, Burisch J, Collins P, Doherty G, El-Hussuna A, Ellul P, Fiorino G, Frei-Lanter C, Furfaro F, Gingert C, Gionchetti P, Gisbert JP, Gomollon F, González Lorenzo M, Gordon H, Hlavaty T, Juillerat P, Katsanos K, Kopylov U, Krustins E, Kucharzik T, Lytras T, Maaser C, Magro F, Marshall JK, Myrelid P, Pellino G, Rosa I, Sabino J, Savarino E, Stassen L, Torres J, Uzzan M, Vavricka S, Verstockt B, Zmora O, European Crohn’s and Colitis Organisation [ECCO] (2020) ECCO Guidelines on therapeutics in Crohn’s disease: surgical treatment. J Crohn's Colitis 14(2):155–168. https://​doi.​org/​10.​1093/​ecco-jcc/​jjz187
4.
Lichtenstein GR, Hannauer SB, Sandborn WJ and the Practice Parameters Committee of the American College of Gastroenterology (2009) Management of Crohn’s disease in adults. Am J Gastroenterol
5.
Werbin N, Haddad R, Greenberg R et al (2003) Free perforation in Crohn’s disease. Isr Med Assoc J 5(3):175–177
6.
Yamaguchi A, Matsui T, Sakurai T et al (2004) The clinical characteristics and outcome of intraabdominal abscess in Crohn’s disease. J Gastroenterol 39(5):441–448CrossRef
7.
Polle S, Wind J, Ubbink D et al (2006) Short-term outcomes after laparoscopic ileocolic resection for Crohn’s disease. A systematic review Dig Surg 23:346–357
8.
Farmer RG, Whelan G, Fazio VW (1985) Long-term follow-up of patients with Crohn’s disease. Relationship between the clinical pattern and prognosis. Gastroenterology 88:1818–1825. [PMID: 3922845]CrossRef
9.
Michelassi F, Balestracci T, Chappell R, Block GE (1991) Primary and recurrent Crohn’s disease. Experience with 1379 patients. Ann Surg 214:230–238. discussion 238–240 [PMID: 1929605]CrossRef
10.
11.
12.
Appau KA, Fazio VW, Shen B et al (2008) Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn’s patients. J Gastrointest Surg 12:1738–1744CrossRef
13.
Kopylov U, Ben-Horin S, Zmora O, Eliakim R, Katz LH (2012) Anti-tumor necrosis factor and postoperative complications in Crohn’s disease: systematic review and meta-analysis. Inflamm Bowel Dis 18:2404–2413CrossRef
14.
Post S, Betzler M, von Ditfurth B et al (1991) Risks of intestinal anastomoses in Crohn’s disease. Ann Surg 213:37–42CrossRef
15.
Bafford AC, Powers S, Ha C et al (2013) Immunosuppressive therapy does not increase operative morbidity in patients with Crohn’s disease. J Clin Gastroenterol 47:491–495CrossRef
16.
Bruewer M, Utech M, Rijcken EJ et al (2003) Preoperative steroid administration: effect on morbidity among patients undergoing intestinal bowel resection for Crohns disease. World J Surg 27:1306–1310CrossRef
17.
Kasparek MS, Bruckmeier A, Beigel F et al (2012) Infliximab does not affect postoperative complication rates in Crohn’s patients undergoing abdominal surgery. Inflamm Bowel Dis 18:1207–1213CrossRef
18.
Indar AA, Young-Fadok TM, Heppell J, Efron JE (2009) Effect of perioperative immunosuppressive medication on early outcome in Crohn’s disease patients. World J Surg 33:1049–1052CrossRef
19.
Mascarenhas C, Nunoo R, Asgeirsson T, Rivera R, Kim D, Hoedema R, Dujovny N, Luchtefeld M, Davis AT, Figg R (2012) Outcomes of ileocolic resection and right hemicolectomies for Crohn’s patients in comparison with non-Crohn’s patients and the impact of perioperative immunosuppressive therapy with biologics and steroids on inpatient complications. Am J Surg 203(3):375–378. https://​doi.​org/​10.​1016/​j.​amjsurg.​2011.​11.​001. [PMID: 22364904]CrossRef
20.
21.
22.
Rosenfeld G, Qian H, Bressler B (2013) The risks of postoperative complications following pre-operative infliximab therapy for Crohn’s disease in patients undergoing abdominal surgery: a systematic review and meta-analysis. J Crohns Colitis 7(11):868–877CrossRef
23.
de Buck van Overstraeten A, Eshuis EJ, Vermeire S, Van Assche G, Ferrante M, D’Haens GR et al (2017) Short- and medium-term outcomes following primary ileocaecal resection for Crohn’s disease in two specialist centres. Br J Surg 104(12):1713–1722CrossRef
24.
Yamamoto T, Spinelli A, Suzuki Y, Saad-Hossne R, Teixeira FV, de Albuquerque IC et al (2016) Risk factors for complications after ileocolonic resection for Crohn’s disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: a retrospective international multicentre study. United European Gastroenterol J 4(6):784–793CrossRef
25.
Ahmed Ali U, Martin ST, Rao AD, Kiran RP (2014) Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn’s disease. Dis Colon Rectum 57(5):663–674CrossRef
26.
McKenna NP, Habermann EB, Glasgow AE, Dozois EJ, Lightner AL (2018) Intra-abdominal sepsis after ileocolic resection in Crohn’s disease: the role of combination immunosuppression. Dis Colon Rectum 61(12):1393–1402CrossRef
27.
Yamamoto T, Allan RN, Keighley MR (2000) Risk factors for intra-abdominal sepsis after surgery in Crohn’s disease. Dis Colon Rectum 43:1141–1145CrossRef
28.
Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P (2007) Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn’s disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 50(3):331–336CrossRef
29.
30.
Kanazawa A, Yamana T, Okamoto K, Sahara R (2012) Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn’s disease. Dis Colon Rectum 55(9):957–962CrossRef
31.
Iesalnieks I, Kilger A, Glass H, Müller-Wille R, Klebl F, Ott C, Strauch U, Piso P, Schlitt HJ, Agha A (2008) Intraabdominal septic complications following bowel resection for Crohn’s disease: detrimental influence on long-term outcome. Int J Colorectal Dis 23:1167–1174. [PMID: 18690466]CrossRef
32.
Huang W, Tang Y, Nong L, Sun Y (2015) Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn’s disease: a meta-analysis of observational studies. J Crohns Colitis 9(3):293–301CrossRef
33.
Frolkis AD, Dykeman J, Negrón ME et al (2013) Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 145(5):996–1006CrossRef
Metadata
Title
Effect of immunosuppressive medication on postoperative complications following abdominal surgery in Crohn’s disease patients
Authors
Saleh Lahes
Celine Fischer
Antonios E. Spiliotis
Antje Schulz
Gereon Gäbelein
Dorian Igna
Matthias Glanemann
Publication date
28-11-2022
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Colorectal Disease / Issue 12/2022
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-022-04287-4

Other articles of this Issue 12/2022

International Journal of Colorectal Disease 12/2022 Go to the issue

Review

Preoperative carbohydrate loading before colorectal surgery: a systematic review and meta-analysis of randomized controlled trials

Research

A clinical prediction model for the presence of brain metastases from colorectal cancer

Research

Adjuvant chemotherapy benefits on patients with elevated carcinoembryonic antigen in stage IIA colon cancer: a SEER-based analysis

Review

Open versus laparoscopic Hartmann’s procedure: a systematic review and meta-analysis

Research

Preoperative prediction of lymph node status in patients with colorectal cancer. Developing a predictive model using machine learning

Research

Incidence and causes of failure in various anatomical pouch designs 20 years after surgical primary ileal-pouch anal anastomosis construction